Odyssey Health, Inc.
For the period ended Apr 30, 2026. Filed Jun 12, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Apr 30, 2026 · Filed Jun 12, 2026
ODYYStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Item 6. | Exhibits |
|---|
The following exhibits are filed herewith and this list constitutes the exhibit index.
| Exhibit Number | Exhibit Description |
| 10.1 | Master Technology and Sub-License Agreement between Odyssey Health, Inc. and NeuRX Health, Inc (incorporated by reference to Exhibit 10.1 to Form 8-K filed with the SEC on October 17, 2025). |
| 10.2 | Amendment No. 1, dated April 21, 2026, to the Master Technology and Sub-License Agreement dated October 14, 2025 (incorporated by reference to Exhibit 10.2 to Form 8-K filed with the SEC on April 24, 2026). |
| 10.3 | NeuRX Health, Inc. Revocation Letter dated May 6, 2026 (incorporated by reference to Exhibit 10.1 to Form 8-K filed with the SEC on May 11, 2026) |
| 10.4 | Form of Amendment No. 12 dated January 30, 2026, to Convertible Promissory Note with Directors and Officers, dated December 21, 2021 and December 22, 2021 (incorporated by reference to Exhibit 10.1 to Form 8-K filed with the SEC on February 3, 2026) |
| 10.5 | Amendment No. 11 dated January 30, 2026 to Convertible Promissory Note with LGH Investments, LLC dated April 5, 2021 (incorporated by reference to Exhibit 10.2 to Form 8-K filed with the SEC on February 3, 2025). |
| 10.6 | Amendment No. 5 dated January 30, 2026, to the Promissory Note with accredited investor Jonathan Lutz, dated February 13, 2024 (incorporated by reference to Exhibit 10.3 to Form 8-K filed with the SEC on February 3, 2025) |
| 10.7 | Amendment No. 2 dated February 2, 2026 and effective January 30, 2026, to the Promissory Note with accredited investor Peter J. D’Arruda, dated August 14, 2024 (incorporated by reference to Exhibit 10.4 to Form 8-K filed with the SEC on February 3, 2026) |
| 10.8 | Amendment No. 12 dated May 18, 2026 to Convertible Promissory Note with LGH Investments, LLC dated April 5, 2021 (incorporated by reference to Exhibit 10.1 to Form 8-K filed with the SEC on May 26, 2026). |
| 10.9 | Amendment No. 6 dated October 9, 2025 to Promissory Note issued December 13, 2022 with Mast Hill Fund, L.P (incorporated by reference to Exhibit 10. 1 to Form 8-K filed with the SEC on October 10, 2025) |
| 10.10 | Amendment No. 7 dated June 9, 2026 to Promissory Note issued December 13, 2022 with Mast Hill Fund, L.P.** |
| 31.1 | Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934 |
| 31.2 | Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934 |
| 32.1 | Certification of Chief Executive Officer pursuant to Section 1350 |
| 32.2 | Certification of Chief Financial Officer pursuant to Section 1350 |
| 101.INS | Inline XBRL Instances Document |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (formatted in iXBRL, and included in exhibit 101). |
** Filed herewith
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.